Development of Rationally Designed, Target-Based Agents for the Treatment of Advanced Colorectal Cancer

This publication has 119 references indexed in Scilit:

• Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
  New England Journal of Medicine, 2002
• Mutations of the BRAF gene in human cancer
  Nature, 2002
• 4E-binding Proteins, the Suppressors of Eukaryotic Initiation Factor 4E, Are Down-regulated in Cells with Acquired or Intrinsic Resistance to Rapamycin
  Journal of Biological Chemistry, 2002
• NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
  The EMBO Journal, 2000
• Regulation of β-Catenin Signaling in the Wnt Pathway
  Biochemical and Biophysical Research Communications, 2000
• The Hallmarks of Cancer
  Cell, 2000
• Safety and antitumor activity of recombinant soluble Apo2 ligand
  Journal of Clinical Investigation, 1999
• Induction of NF-κB by the Akt/PKB kinase
  Current Biology, 1999
• Apoptosis in the Pathogenesis and Treatment of Disease
  Science, 1995
• Apoptosis of Lung Cancer Cells Caused by Some Anti-cancer Agents (MMC, CPT-11, ADM) is Inhibited by BCL-2
  Biochemical and Biophysical Research Communications, 1993